[Federal Register Volume 68, Number 172 (Friday, September 5, 2003)]
[Notices]
[Page 52775]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-22581]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Food Biotechnology Subcommittee of the Food Advisory Committee; 
Notice of Meeting

AGENCY:  Food and Drug Administration, HHS.

ACTION:  Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.
    Name of Committee: Food Biotechnology Subcommittee of the Food 
Advisory Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on September 24, 2003, from 
8:30 a.m. to 4:30 p.m.
    Location: JW Marriott Hotel, 1331 Pennsylvania Ave., Washington, 
DC, 202-314-4714.
    Contact Person: Michael Watson, Center for Food Safety and Applied 
Nutrition (HFS-255), Food and Drug Administration, 5100 Paint Branch 
Pkwy., College Park, MD 20740, 202-418-3122, or FDA Advisory Committee 
Information Line, 1-800-741-8138 301-443-0572 in the Washington, DC 
area), code 10564. Please call the Information Line for up-to-date 
information on this meeting.
    Agenda: The purpose of the meeting is to discuss the science-based 
approaches to the molecular characterization of bioengineered foods as 
part of FDA's safety assessment.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by September 10, 
2003. Oral presentations from the public will be scheduled between 
approximately 1 p.m. to 2 p.m. Time allotted for each presentation may 
be limited. Those desiring to make formal oral presentations should 
notify the contact person before September 10, 2003, and submit a brief 
statement of the general nature of the evidence or arguments they wish 
to present, the names and addresses of proposed participants, and an 
indication of the approximate time requested to make their 
presentation.
    Persons attending FDA's advisory committee meetings are advised 
that the agency is not responsible for providing access to electrical 
outlets.
    FDA welcomes the attendance of the public at its advisory committee 
meetings and will make every effort to accommodate persons with 
physical disabilities or special needs. If you require special 
accommodations due to a disability, please contact Michael Watson at 
least 7 days in advance of the meeting.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: August 28, 2003.
Peter J. Pitts,
Asssociate Commissioner for External Affairs.
[FR Doc. 03-22581 Filed 9-4-03; 8:45 am]
BILLING CODE 4160-01-S